Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 1.00 |
| ▸ | DRD1 | P21728 | 1/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 1/20 | 1.00 |
| ▸ | PDE4A | P27815 | 1/20 | 1.00 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.38 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.38 |
| ▸ | KCNMB4 | Q86W47 | 1/20 | 0.38 |
| ▸ | ALB | P02768 | 1/20 | 0.37 |
| ▸ | F11 | P03951 | 1/20 | 0.37 |
| ▸ | KRAS | P01116 | 1/20 | 0.37 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.37 |
| ▸ | TSLP | Q969D9 | 1/20 | 0.36 |
| ▸ | SHH | Q15465 | 1/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.36 |
| ▸ | ITGAV | P06756 | 1/20 | 0.36 |
| ▸ | NECTIN4 | Q96NY8 | 2/20 | 0.36 |
| ▸ | OXTR | P30559 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Daptomycin SCHEMBL28102 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL17253124 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL8221756 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL8221760 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL2724847 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL16274142 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL23046993 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL13491700 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL21402170 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 | |
| Daptomycin SCHEMBL8227262 | 1.00 | CTSL (1.00) | CTSLDRD1PTGS1PDE4AF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724107-A2 | OPHTHALMIC FILMS | Fount Bio, Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| CN-119874830-A | Preparation method of daptomycin stable crystal form | 南京工业大学 | 2025-04-25 | — | — | CN | disclosed |
| WO-2024254278-A9 | OPHTHALMIC FILMS | FOUNT BIO, INC. (US) | 2025-02-13 | — | — | WO | disclosed |
| WO-2024254278-A2 | OPHTHALMIC FILMS | FOUNT BIO, INC. (US) | 2024-12-12 | — | — | WO | disclosed |
| CN-113710225-B | Delivery and retention of active agents within the skin | 范德生物公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-113943710-B | Culture medium for CAR-T cell culture and application thereof | 浙江大学医学院附属第一医院 | 2023-03-24 | — | — | CN | disclosed |
| CN-108350030-B | Skin permeable peptides and methods of use thereof | 汉阳大学校产学协力团 | 2022-12-13 | — | — | CN | disclosed |
| EP-3641753-B1 | BACITRACIN AND/OR DAPTOMYCIN COMBINED WITH CANNABIDIOL FOR TREATMENT OF BACTERIAL INFECTIONS | UNIV SYDDANSK (DK) | 2022-09-21 | — | — | EP | disclosed |
| CN-114814046-B | Method for rapidly detecting daptomycin in meat food and application | 南京市食品药品监督检验院 | 2022-09-16 | — | — | CN | disclosed |
| CN-114814046-A | Method for rapidly detecting daptomycin in meat food and application | 南京市食品药品监督检验院 | 2022-07-29 | — | — | CN | disclosed |
| WO-2016033314-A1 | SKIN PENETRATING PEPTIDES (SPPS) AND METHODS OF USE THEREFOR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-03-03 | — | — | WO | disclosed |
| US-20150366985-A1 | ANTI-WALL TEICHOIC ANTIBODIES AND CONJUGATES | GENENTECH, INC. (US) | 2015-12-24 | — | — | US | disclosed |
| US-20140227174-A1 | SKIN PERMEATING AND CELL ENTERING (SPACE) PEPTIDES AND METHODS OF USE THEREFOR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-08-14 | — | — | US | disclosed |
| US-20140161871-A1 | SKIN PERMEATING AND CELL ENTERING (SPACE) PEPTIDES AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-06-12 | — | — | US | disclosed |
| EP-2638162-A2 | SKIN PERMEATING AND CELL ENTERING (SPACE) PEPTIDES AND METHODS OF USE THEREOF | The Regents of the University of California (US) | 2013-09-18 | — | — | EP | disclosed |
| US-8518871-B2 | Skin permeating and cell entering (SPACE) peptides and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-08-27 | — | — | US | disclosed |
| CN-103201386-A | Skin penetrating and cell entering (SPACE) peptides and methods of use thereof | UNIV CALIFORNIA | 2013-07-10 | — | — | CN | disclosed |
| WO-2012064429-A2 | SKIN PERMEATING AND CELL ENTERING (SPACE) PEPTIDES AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-05-18 | — | — | WO | disclosed |
| US-7927613-B2 | Pharmaceutical co-crystal compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-04-19 | — | — | US | disclosed |
| US-7790905-B2 | Pharmaceutical propylene glycol solvate compositions | MCNEIL-PPC, INC. (US) | 2010-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150366985-A1 | ANTI-WALL TEICHOIC ANTIBODIES AND CONJUGATES | STT3A, STT3B, DDOST | CTSL 2518/4885DRD1 3783/4885PTGS1 3631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.